J. Luboshitz

发表

Recombinant factor concentrates may increase inhibitor development: a single centre cohort study

G. Kenet, T. Strauss, A. Lubetsky, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Percutaneous iliac bone harvesting technique for maxillary sinus floor augmentation.

J. Luboshitz, I. Keidan, U. Berger, 2010, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange.

K. Jurk, J. Luboshitz, R. Farndale, 2002, Blood.

Treatment tailoring for factor V deficient patients and perioperative management using global hemostatic coagulation assays.

G. Kenet, J. Luboshitz, M. Misgav, 2018, Blood cells, molecules & diseases.

A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven®)

G. Kenet, A. Lubetsky, J. Luboshitz, 2003, Journal of thrombosis and haemostasis : JTH.

Recombinant activated factor VII for adjunctive hemorrhage control in trauma.

E. Segal, G. Kenet, J. Luboshitz, 2001, The Journal of trauma.

Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma.

E. Segal, G. Kenet, J. Luboshitz, 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C‐infected haemophilia patients

J. Schapiro, Y. Maor, G. Kenet, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Non‐invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?

Y. Maor, G. Kenet, D. Bashari, 2006, Haemophilia.

Mutations in RASGRP2 gene identified in patients misdiagnosed as Glanzmann thrombasthenia patients.

H. Tamary, O. Barel, G. Kenet, 2021, Blood cells, molecules & diseases.

Efficacy and safety of a factor VIII–von Willebrand factor concentrate 8Y: stability, bacteriological safety, pharmacokinetic analysis and clinical experience

G. Kenet, A. Lubetsky, J. Luboshitz, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

Hepatitis C at the Israeli National Hemophilia Center

J. Schapiro, Y. Maor, G. Kenet, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

Protein disulfide isomerase mediates integrin‐dependent adhesion

J. Luboshitz, J. Lahav, M. Shaklai, 2000, FEBS letters.

Congenital anomalies of the inferior vena cava revealed on CT in patients with deep vein thrombosis.

A. Lubetsky, J. Luboshitz, S. Apter, 2003, AJR. American journal of roentgenology.

Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors

G. Kenet, A. Lubetsky, B. Ravid, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4+ T cell response to β2GPI

Y. Shoenfeld, M. Blank, S. Kivity, 2011, Annals of the rheumatic diseases.

Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII

G. Kenet, A. Lubetsky, J. Luboshitz, 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

enzymatically catalyzed disulfide exchange Sustained integrin ligation involves extracellular free sulfhydryls and

K. Jurk, J. Luboshitz, R. Farndale, 2013 .

Cutaneous necrosis as a terminal paraneoplastic thromboembolic event in a patient with non‐Hodgkin’s lymphoma

O. Bairey, J. Luboshitz, M. Prokocimer, 1999, Journal of internal medicine.

Oxygen Uptake Kinetics during Exercise Reveal Central and Peripheral Limitation in Patients with Ilio-Femoral Venous Obstruction.

Andrew M. Jones, J. Luboshitz, R. Reuveny, 2021, Journal of vascular surgery. Venous and lymphatic disorders.

Chronic iliofemoral vein obstruction – an under-recognized cause of exercise limitation‡

J. Luboshitz, R. Reuveny, I. Ben-Dov, 2018, European journal of sport science.

The Management of Giant Haemophilic Pseudotumours

E. Rodríguez‐Merchán, Y. Amit, N. Goddard, 2008 .

Haemophilia B and other bleeding disorders

J. Oldenburg, S. Rost, V. Ivaškevičius, 2000 .

Stability, efficacy, and safety of continuously infused sucrose‐formulated recombinant factor VIII (rFVIII‐FS) during surgery in patients with severe haemophilia

H. Stass, A. Lubetsky, B. Ravid, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Haemophilia A

S. Rost, V. Ivaškevičius, J. Luboshitz, 2000 .

Evaluation of Stability of a Sucrose-Formulated, Full-Length rFVIII for Use in Continuous Infusion Therapy.

A. Lubetsky, J. Luboshitz, U. Martinowitz, 2004 .

Women with Hemophilia: Case Series of Reproductive Choices and Review of Literature

G. Kenet, D. Bashari, J. Luboshitz, 2021, TH Open.

Infusion rates of recombinant FVIII‐FS with PEGylated liposomes in haemophilia A

J. Spira, J. Luboshitz, S. Lalezari, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Platelet-Rich Plasma for Bone Graft Enhancement in Sinus Floor Augmentation With Simultaneous Implant Placement: Patient Series Study

Ziv Mazor, Arun K Garg, A. Garg, 2004, Implant dentistry.

Human T lymphotropic virus type 1 in a seronegative B chronic lymphocytic leukemia patient

J. Luboshitz, W. Bodemer, P. Stark, 2003, Medical Microbiology and Immunology.

[Platelet rich plasma (PRP) as adjuvant tool for bone augmentation].

J. Luboshitz, U. Berger, O. Yaari, 2004, Refu'at ha-peh veha-shinayim.

Treatment of antithyroid drug-induced agranulocytosis by granulocyte colony-stimulating factor: a case of primum non nocere.

J. Luboshitz, I. Blum, D. Hirsch, 1999, Thyroid : official journal of the American Thyroid Association.

From thrombasthenia to next generation thrombocytopenia: Neonatal alloimmune thrombocytopenia induced by maternal Glanzmann thrombasthenia

G. Kenet, J. Luboshitz, N. Rosenberg, 2018, Pediatric blood & cancer.

Basic and translational research

Y. Shoenfeld, M. Blank, S. Kivity, 2011 .

Pharmacokinetic Studies with FVIII/von Willebrand Factor Concentrate Can Be a Diagnostic Tool to Distinguish between Subgroups of Patients with Acquired von Willebrand Syndrome

A. Lubetsky, J. Luboshitz, A. Lubetsky, 2001, Thrombosis and Haemostasis.

BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocytopenia patients: clinical presentation.

O. Bairey, J. Luboshitz, M. Prokocimer, 1997, Blood.

Significance of BCR-ABL transcripts in bone marrow aspirates of Philadelphia-negative essential thrombocythemia patients.

O. Bairey, J. Luboshitz, M. Prokocimer, 1999, Leukemia & lymphoma.

A novel Phe171Cys mutation in integrin αIIb causes Glanzmann thrombasthenia by abrogating αIIbβ3 complex formation

M. Landau, G. Rechavi, J. Luboshitz, 2004, Journal of thrombosis and haemostasis : JTH.

Efficacy, PK and Safety Results of a Phase I/II Clinical Trial of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Haemophilia B (PROLONG - 9FP)

E. Santagostino, T. Lissitchkov, A. Lubetsky, 2012 .

Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4+ T cell response to β2GPI

Y. Shoenfeld, M. Blank, S. Kivity, 2012 .

Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4 + T cell

Y. Shoenfeld, M. Blank, S. Kivity, 2011 .

Haemophilia A

S. Rost, V. Ivaškevičius, J. Luboshitz, 2000 .

Hepatic Lesions of Chronic Disseminated Systemic Candidiasis in Leukemia Patients May Become Visible During Neutropenia: Value of Serial Ultrasound Examinations

J. Sulkes, O. Bairey, J. Luboshitz, 1998 .

Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors

G. Kenet, B. Ravid, J. Luboshitz, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.